4//SEC Filing
Cukier Herm 4
Accession 0001103021-20-000028
CIK 0001103021other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:25 PM ET
Size
9.3 KB
Accession
0001103021-20-000028
Insider Transaction Report
Form 4
Cukier Herm
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2020-01-31+31,250→ 67,631 total - Sale
Common Stock
2020-02-03$5.16/sh−31,850$164,346→ 35,781 total - Exercise/Conversion
Restricted Stock Units
2020-01-31−31,250→ 62,500 totalExercise: $0.00Exp: 2022-01-31→ Common Stock (31,250 underlying)
Footnotes (3)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on January 31, 2019, under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest equally on January 31, 2021 and January 31, 2022.
- [F2]The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan, 11,850 of which were sold to cover the Reporting Person's tax liability upon the vesting of the RSUs.
- [F3]On February 3, 2019, the Reporting Person sold an aggregate of 31,850 shares of the Issuer's Common Stock at a weighted average price of $5.16 per share. The highest sale price for the Common Stock was $5.24 per share and the lowest sale price was $5.10 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001739458
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:25 PM ET
- Size
- 9.3 KB